3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Pain, Postoperative
4
Prostatic Neoplasms
3
Postoperative Hemorrhage
2
Neoplasms
2
Kidney Neoplasms
2
Delirium
2
Colorectal Neoplasms
2
Central Nervous System Diseases
2
Brain Neoplasms
2
Thyroid Neoplasms
1
Thromboembolism
1
Surgical Wound Infection
1
Spondylitis, Ankylosing
1
Sleep Deprivation
1
Skin Neoplasms
1
Skin Diseases
1
Seroma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Shivering
1
Pleural Effusion, Malignant
1
Pituitary Neoplasms
1
Pituitary Diseases
1
Ovarian Neoplasms
1
Neuroinflammatory Diseases
1
Neurocognitive Disorders
1
Neoplasms, Fibrous Tissue
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms, Connective Tissue
1
Neoplasms by Site
1
Interventions
Acetaminophen
4
Tramadol
3
Fentanyl
3
Bupivacaine
3
Morphine
2
Ketorolac Tromethamine
2
Ketamine
2
Gabapentin
2
Ethanol
2
Analgesia, Epidural
2
oxycodone-acetaminophen
1
acetaminophen, codeine drug combination
1
acetaminophen, aspirin, caffeine drug combination
1
Varenicline
1
Therapeutics
1
Sodium Chloride
1
Saline Solution
1
Ropivacaine
1
Radiofrequency Ablation
1
Pregabalin
1
Oxycodone
1
Orphenadrine
1
Methadone
1
Meperidine
1
Magnesium
1
Lidocaine
1
Ketorolac
1
Hydromorphone
1
Hydrocodone
1
Entonox
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Agnosia
×
Sodium Chloride
×
Clear all
NCT00519246
2009-03-31
COPTEAM
Nanjing Medical University
Phase 4
Completed
2,000 enrolled